Educational Session 1: Biomarker-guided Precision Therapy in Metastatic Breast Cancer 

Presentation numberED1-01

Moderator

Philippe Bedard

Presentation numberED1-02

Actionable Mutations Beyond PIK3CA and ESR1 in HR Positive HER2 Negative Breast Cancer

Maria Coakley, BC Cancer Vancouver, Vancouver, BC, Canada

Presentation numberED1-03

HER2-Low to HER2-Ultralow: Redefining HER2-Targeted Therapy

Shanu Modi

Presentation numberED1-04

Immune Biomarkers Driving Immunotherapy Selection in Metastatic TNBC

Giampaolo Bianchini, IRCCS San Raffaele Hospital, MIlan, Italy

Presentation numberED1-05

Biomarkers for the WIN!

Kelly Shanahan